|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：K090002 |
| 產(chǎn)品名稱：KAD-1229-d8 Calcium Hydrate |
| 產(chǎn)品CAS：1346603-13-1 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
K090002 |
| 名稱: |
KAD-1229-d8 Calcium Hydrate |
| 別名: |
(S)-2-Benzyl-4-oxo-4-(cis-perhydroisoindol-2-yl)butyric Acid-d8 Calcium Salt Hydrate; Mitiglinide-d8 Calcium Hydrate; |
| CAS號: |
1346603-13-1 |
| 參考CAS號: |
類似: 207844-01-7 |
| 分子式: |
C??H??D?NO?•1/2Ca |
| 外觀: |
白色固體 |
| 熔點: |
>187ºC (dec.) |
| 分子量: |
361.51 |
| 儲存: |
Hygroscopic, 冰箱, Under Inert Atmosphere |
| 溶解度: |
Methanol (Slightly) |
| 種類: |
Standards; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應用: |
KAD-1229 binds to sulfonylurea receptors and inhibits the activity of ATP-sensitive K+ channel in MIN 6 cells. Antidiabetic. |
| 參考文獻 |
|
|
|
|
?您的位置：
